ETF Managers Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$2.26M Buy
15,988
+4,241
+36% +$607K 0.07% 145
2022
Q4
$1.84M Sell
11,747
-5,032
-30% -$723K 0.09% 114
2022
Q3
$2.05M Buy
16,779
+1,008
+6% +$133K 0.07% 151
2022
Q2
$2.17M Buy
15,771
+6,064
+62% +$826K 0.06% 157
2022
Q1
$1.35M Sell
9,707
-4,066
-30% -$567K 0.03% 246
2021
Q4
$2.36M Sell
13,773
-4,387
-24% -$668K 0.05% 199
2021
Q3
$2.68M Buy
18,160
+1,295
+8% +$189K 0.05% 177
2021
Q2
$2.24M Sell
16,865
-1,631
-9% -$214K 0.04% 212
2021
Q1
$2.38M Sell
18,496
-8,981
-33% -$1.11M 0.04% 176
2020
Q4
$3.25M Buy
27,477
+1,078
+4% +$131K 0.07% 149
2020
Q3
$3M Buy
26,399
+17,309
+190% +$2.05M 0.1% 132
2020
Q2
$1M Buy
9,090
+5,916
+186% +$627K 0.04% 178
2020
Q1
$264K Buy
3,174
+324
+11% +$33.5K 0.01% 343
2019
Q4
$303K Buy
2,850
+726
+34% +$75.7K 0.01% 372
2019
Q3
$224K Sell
2,124
-9
-0.4% -$924 0.01% 357
2019
Q2
$214K Buy
2,133
+690
+48% +$66.3K 0.01% 347
2019
Q1
$130K Buy
1,443
+121
+9% +$10.5K 0.01% 448
2018
Q4
$110K Buy
1,322
+199
+18% +$18.7K 0.01% 452
2018
Q3
$121K Buy
1,123
+118
+12% +$12.9K ﹤0.01% 386
2018
Q2
$55K Buy
1,005
+291
+41% +$30.3K ﹤0.01% 451
2018
Q1
$70K Buy
714
+88
+14% +$9.01K ﹤0.01% 443
2017
Q4
$62K Buy
626
+88
+16% +$8.34K ﹤0.01% 463
2017
Q3
$50K Buy
538
+50
+10% +$5.31K ﹤0.01% 402
2017
Q2
$54K Buy
+488
New +$51.6K ﹤0.01% 260
2016
Q1
$39K Buy
+394
New +$26.4K 0.03% 167

Other funds holding DGX

ETF Managers Group's DGX Position: Q1 2023 in Review

ETF Managers Group increased its Quest Diagnostics (DGX) stake by 36% in Q1 2023, buying an estimated $607K and bringing the position to 15,988 shares worth $2.26M. The position accounts for 0.07% of the portfolio, ranked #145.

ETF Managers Group first reported a position in DGX in Q1 2016 and has held it in 25 quarters since. The position peaked at $3.25M in Q4 2020. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • ETF Managers Group held 15,988 shares of Quest Diagnostics worth $2.26M as of Q1 2023.
  • ETF Managers Group bought 4,241 Quest Diagnostics shares in Q1 2023, an estimated $607K.
  • Quest Diagnostics made up 0.07% of ETF Managers Group's portfolio in Q1 2023, its #145 holding.
  • ETF Managers Group first reported a position in Quest Diagnostics in Q1 2016 and has held it in 25 quarters since.
  • ETF Managers Group's Quest Diagnostics position peaked at $3.25M in Q4 2020.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.